Skip to content

Study to compare different oxygen concentrations administered during birth resuscitation of preterm neonates

Initial Oxygen For Delivery Room Resuscitation Of Preterm Neonates: A Triple-arm, Multi-site, Randomised, Controlled Trial - PORTAL - Preterm Oxygen for Resuscitation Trial At deLivery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094952
Enrollment
700
Registered
2025-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P916- Hypoxic ischemic encephalopathy [HIE] Health Condition 2: P039- Newborn affected by complication of labor and delivery, unspecified Health Condition 3: P073- Preterm [premature] newborn [other]

Interventions

Intervention1: Initiating resuscitation with 90% initial FiO2 by T-piece: Resuscitation with 90% initial FiO2 by T-piece till a reliable recording of preductal pulse oxygen saturation is available fol

Sponsors

Venkataseshan Sundaram
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Consecutively born preterm neonates of less than 32 completed weeks of gestation and requiring delivery room (DR) resuscitation with positive pressure ventilation (PPV) as per the most recent neonatal resuscitation program (NRP) guidelines will be included.

Exclusion criteria

Exclusion criteria: Pregnant women with insufficient time during the antenatal period to administer and obtain an informed consent Antenatally suspected or proven major structural anomalies (those responsible for death, morbidities and disability related to congenital anomalies - as per CDC definition) Parental request or neonatologist decision to forego resuscitation Refusal of consent

Design outcomes

Primary

MeasureTime frame
A composite of all-cause mortality or bronchopulmonary dysplasia with the end point of assessment being death or 44 weeks post-menstrual age, whichever is earlier.Timepoint: Death or 44 weeks post-menstrual age, whichever is earlier.

Secondary

MeasureTime frame
A composite of all-cause mortality or bronchopulmonary dysplasia or retinopathy of prematurity requiring treatment or necrotising enterocolitis (definite or advanced stages) or brain injury (major intra-ventricular hemorrhage or periventricular leukomalacia) with the end point of assessment being death or 44 weeks post-menstrual age, whichever is earlier.Timepoint: Death or 44 weeks post-menstrual age, whichever is earlier.;Structural changes in brain as assessed by MRI brain.Timepoint: 44 weeks PMA (term equivalent age).

Countries

India

Contacts

Public ContactVenkataseshan Sundaram

Post Graduate Institute of Medical Education and Research

venkatpgi@gmail.com2755340

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026